Okomera logo

Okomera

We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity

http://www.okomera.com
11-50 employees

Growth Trajectory

Okomera, having recently raised €10.2m, is positioned to expand its personalized medicine development platform and further develop its high-throughput screening capabilities. Their focus on scalable CRISPR screening and combinatorial drug screening indicates potential for growth within the oncology market, potentially extending into other areas of personalized medicine.

Technical Challenges

Scaling standard 2D assays to 3D organoid on chip
High-throughput screening of organoids
Automation of organoid handling and analysis
Ensuring reproducibility and standardization of organoid assays.

Tech Stack

Microfluidics-on-chip3D cell cultureDroplet-based microfluidicsAI analysis platform

Team Size

Key Risks

Adoption of novel 3D organoid screening technology may face resistance from established 2D assay methods.
Competition from existing preclinical screening platforms with established market presence.
Scalability challenges in maintaining assay quality and consistency with high-throughput organoid screening.
Regulatory hurdles in translating 3D organoid screening results into clinical applications.

Opportunities

Leveraging AI-driven analysis to improve the accuracy and efficiency of drug screening.
Expanding into new therapeutic areas beyond oncology, such as toxicology and regenerative medicine.
Partnering with pharmaceutical companies to integrate Okomera's platform into their drug discovery workflows.
Developing a comprehensive database of organoid screening data to accelerate personalized medicine research.
Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats